Capsules make patients grow blood vessels
Wednesday 03 November 1999
The capsules slowly released a growth-promoting substance over a period of several weeks. It improved the flow of blood to the heart and made the patients feel better. Scientists emphasised that the clinical trial involved only 24 patients and further studies on hundreds of volunteers will be needed before the approach could be proved to be an acceptable alternative to coronary bypass surgery.
Instead of grafting arteries or veins from other parts of the body to bypass a clogged heart vessel, the scientists used the slow release of the growth factor to stimulate the regrowth of existing blood vessels.
Michael Simons, associate professor of medicine at Harvard Medical School and a member of the research team, said the technique produced demonstrable improvements. "Patients receiving the highest dose of the growth factor showed an improvement in blood supply and heart function, while the patients receiving the much lower doses of the growth factor or those not receiving the treatment had no increase in blood flow or heart function," Professor Simons said.
Over the past 20 years coronary bypass operations in Britain have increased 20-fold, with about 23,000 operations now being performed each year at a cost of about pounds 4,000 each. Many of the operations are the result of a constriction of the flow of blood to the heart that results in a lack of oxygen and, eventually, to the development of heart disease, which can be lethal. The team of doctors took 24 patients who were unable to have coronary bypass operations for a variety of reasons and who therefore had a portion of their hearts that were inadequately oxygenated.
Eight of the patients had 10 capsules with full-strength growth factor inserted into the fatty deposits next to the inoperable artery, eight received capsules loaded with lower doses and the final eight "controls" received capsules with no growth factor at all. After several weeks, all the patients on the full dose capsules said they had no angina (chest pain associated with badly oxygenated heart muscle), whereas one of the lower dose groups and three of the eight controls complained of chest pains.
Further tests showed that the high-dose capsules had also significantly improved the flow of blood to the heart and substantially reduced the area of heart tissue with inadequate blood flow - from about 19 per cent before the therapy to 9 per cent.
The British Heart Foundation said the concept of using growth factors to repair the heart's arteries was "conceptually exciting" but there was still much work to be done before it could be offered as an alternative to surgery.
- 1 Nigel Farage: Me vs Russell Brand on Question Time – he's got the chest hair but where are his ideas?
- 2 Harry Potter fans can apply to the Hogwarts-inspired College of Wizardry
- 3 Jessica Chambers: 19-year-old woman 'doused with lighter fluid and burned alive' in the US
- 4 Russell Brand calls Nigel Farage 'poundshop Enoch Powell' in BBC Question Time debate
- 5 Orange Wednesdays are no more
Weather bomb in pictures: Storms cuts power for tens of thousands – and snow is on the way
Jessica Chambers: 19-year-old woman 'doused with lighter fluid and burned alive' in the US
Russell Brand calls Nigel Farage 'poundshop Enoch Powell' in BBC Question Time debate
Russell Brand was rendered speechless on Question Time by this man
Fury at Airbus after it hints the super-jumbo may be mothballed
Disgruntled RBS worker writes hilarious open letter to Russell Brand after anti-capitalist publicity stunt leaves him hungry
Nigel Farage defends Kerry Smith 'ch***y' comment: 'If you are going for a Chinese, what do you say you’re going for?'
Nigel Farage's approval rating hits 'record low' as popularity suffers in wake of Ukip sex scandal
Pakistan school attack live: Taliban kill at least 132 children in 'horrifying' massacre
Sony hack: Angelina Jolie branded 'seriously out of her mind' in further embarrassing leaked email saga
Panic Saturday: 13 million Britons spend £1.2bn – while 13 million others across the country live in poverty unable to afford food
£23000 - £25000 per annum: Recruitment Genius: This leading provider of design...
£25000 per annum: Ashdown Group: IT Service Desk Analyst - Chessington, Surrey...
£16000 - £19000 per annum: Recruitment Genius: Our client is the UK's leading ...
£45000 - £55000 per annum + benefits: The Jenrick Group: Finance Manager/Manag...